Signal integration in TGF-β,WNT, and Hippo pathways

F1000Prime Reports

Volumn 5, Issue , 2013, Pages

  Attisano, Liliana ^a   Wrana, Jeffrey L ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; ARTICLE; CELL COMMUNICATION; CELL CONTACT; CELL FUNCTION; HOMEOSTASIS; NONHUMAN; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84880055491     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P5-17     Document Type: Article

References (95)

1. Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB: Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res 1982, 42:4776-8. (Pubitemid 13205989)
2. Massague J: Type beta transforming growth factor from feline sarcoma virus-transformed rat cells. Isolation and biological properties. J Biol Chem 1984, 259:9756-61. (Pubitemid 14058584)
3. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF: Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 1987, 237:1333-6. (Pubitemid 17125439)
4. Tucker RF, Shipley GD, Moses HL, Holley RW: Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 1984, 226:705-7. (Pubitemid 15202152)
5. Massague J: TGFbeta signalling in context. Nat Rev Mol Cell Biol 2012, 13:616-30.
6. Weiss A, Attisano L: The TGFbeta Superfamily Signaling Pathway. WIREs Devl Biol 2013, 2:47-63.
7. Moustakas A, Heldin CH: The regulation of TGFbeta signal transduction. Development 2009, 136:3699-714.
8. Attisano L, Wrana JL: Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-7.
9. Bierie B, Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006, 6:506-20. (Pubitemid 43980540)
10. Feng XH, Derynck R: Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-93. (Pubitemid 41740650)
11. Schmierer B, Hill CS: TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007, 8:970-82. (Pubitemid 350174642)
12. Bernabeu C, Lopez-Novoa JM, Quintanilla M: The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 2009, 1792:954-73.
13. Ten Dijke P, Heldin C-H: Smad Signal Transduction. Smads in Proliferation, Differentiation and Disease. In Proteins and Cell Regulation. Volume 5. The Netherlands: Springer; 2006:472.
14. Mu Y, Gudey SK, Landstrom M: Non-Smad signaling pathways. Cell Tissue Res 2011, 347:11-20.
15. Nusse R, Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31:99-109.
16. Clevers H, Nusse R: Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-205.
17. MacDonald BT, Tamai K, He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17:9-26.
18. Nusse R, Varmus H: Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J 2012, 31:2670-84.
19. Minoo P, Li C: Cross-talk between transforming growth factorbeta and Wingless/Int pathways in lung development and disease. The international journal of biochemistry & cell biology 2010, 42:809-12.
20. Attisano L, Labbe E: TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 2004, 23:53-61.
21. Guo X, Wang XF: Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009, 19:71-88.
22. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE, Morrisey EE: Wnt/betacatenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev Biol 2005, 283:226-39. (Pubitemid 40828854)
23. Hoppler S, Moon RT: BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev 1998, 71:119-29. (Pubitemid 28153524)
24. Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y: BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-11.
25. Crease DJ, Dyson S, Gurdon JB: Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A 1998, 95:4398-403. (Pubitemid 28207923)
26. Labbe E, Letamendia A, Attisano L: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 2000, 97:8358-63. (Pubitemid 30639677)
27. Hussein SM, Duff EK, Sirard C: Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 2003, 278:48805-14. (Pubitemid 41079523)
28. Hu MC, Rosenblum ND: Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 2005, 132:215-25. (Pubitemid 40207980)
29. Labbe E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L: Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007, 67:75-84. (Pubitemid 46142761)
30. Bayly R, Axelrod JD: Pointing in the right direction: new developments in the field of planar cell polarity. Nat Rev Genet 2011, 12:385-91.
31. Goodrich LV, Strutt D: Principles of planar polarity in animal development. Development 2011, 138:1877-92.
32. Simons M, Mlodzik M: Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet 2008, 42:517-40.
33. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF: Axin and GSK3-control Smad3 protein stability and modulate TGF-signaling. Genes & development 2008, 22:106-20.
34. Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, Chen YG, Han J, Lin SC: Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J 2006, 25:1646-58.
35. Orsulic S, Peifer M: An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling. J Cell Biol 1996, 134:1283-300. (Pubitemid 26300172)
36. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2001, 2:769-76. (Pubitemid 33679839)
37. Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, De Lau W, Korswagen HC, Schutte M, Clevers H: Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade. J Biol Chem 2009, 284:35308-13.
38. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR: Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 2005, 24:1571-83. (Pubitemid 40646447)
39. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR: Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 2007, 12:957-71. (Pubitemid 46805920)
40. Kaidanovich-Beilin O, Woodgett JR: GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci 2011, 4:40.
41. Inoue Y, Imamura T: Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer science 2008, 99:2107-12.
42. Izzi L, Attisano L: Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 2004, 23:2071-8. (Pubitemid 38496736)
43. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999, 400:687-93.
44. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM: Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-93. (Pubitemid 350138081)
45. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J: Balancing BMP signaling through integrated inputs into the Smad1 linker. Molecular cell 2007, 25:441-54. (Pubitemid 46199289)
46. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL: Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005, 307:1603-9. (Pubitemid 40354739)
47. Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P, Sakuma R, Luga V, Roncari L, Attisano L, Wrana JL: Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell 2009, 137:295-307.
48. Boggiano JC, Fehon RG: Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 2012, 22:695-702.
49. Halder G, Johnson RL: Hippo signaling: growth control and beyond. Development 2011, 138:9-22.
50. Irvine KD: Integration of intercellular signaling through the Hippo pathway. Semin Cell Dev Biol 2012, 23:812-7.
51. Mauviel A, Nallet-Staub F, Varelas X: Integrating developmental signals: a Hippo in the (path) way. Oncogene 2012, 31:1743-56.
52. Pan D: The hippo signaling pathway in development and cancer. Dev Cell 2010, 19:491-505.
53. Varelas X, Wrana JL: Coordinating developmental signaling: novel roles for the Hippo pathway. Trends Cell Biol 2012, 22:88-96.
54. Zhao B, Tumaneng K, Guan KL: The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011, 13:877-83.
55. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, Makita R, Kurihara H, Morin-Kensicki EM, Nojima H, Rossant J, Nakao K, Niwa H, Sasaki H: The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 2009, 16:398-410.
56. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB: TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-8. (Pubitemid 41134465)
57. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, Ding S, Guan KL: The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes & development 2010, 24:1106-18.
58. Zhang H, Pasolli HA, Fuchs E: Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci U S A 2011, 108:2270-5.
59. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD: Yapl acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011, 144:782-95.
60. Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, Lee KP, Oh HJ, Lee SH, Kong YY, Kim JM, Lim DS: A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 2008, 27:1231-42.
61. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR: YAPl increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007, 17:2054-60. (Pubitemid 350180465)
62. Ren F, Wang B, Yue T, Yun EY, Ip YT, Jiang J: Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci U S A 2010, 107:21064-9.
63. Karpowicz P, Perez J, Perrimon N: The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 2010, 137:4135-45.
64. Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, Tapon N: The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 2010, 137:4147-58.
65. Staley BK, Irvine KD: Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 2010, 20:1580-7.
66. Reddy BV, Rauskolb C, Irvine KD: Influence of fat-hippo and notch signaling on the proliferation and differentiation of Drosophila optic neuroepithelia. Development 2010, 137:2397-408.
67. Baena-Lopez LA, Nojima H, Vincent JP: Integration of morphogen signalling within the growth regulatory network. Curr Opin Cell Biol 2012, 24:166-72.
68. McNeill H, Woodgett JR: When pathways collide: collaboration and connivance among signalling proteins in development. Nat Rev Mol Cell Biol 2010, 11:404-13.
69. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL: TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 2008, 10:837-48. (Pubitemid 351927712)
70. Martin-Belmonte F, Perez-Moreno M: Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012, 12:23-38.
71. Genevet A, Polesello C, Blight K, Robertson F, Collinson LM, Pichaud F, Tapon N: The Hippo pathway regulates apicaldomain size independently of its growth-control function. Journal of cell science 2009, 122:2360-70.
72. Hamaratoglu F, Gajewski K, Sansores-Garcia L, Morrison C, Tao C, Halder G: The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth. Journal of cell science 2009, 122:2351-9.
73. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL: The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 2010, 19:831-44.
74. Paramasivam M, Sarkeshik A, Yates JR, 3rd, Fernandes MJ, McCollum D: Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Molecular biology of the cell 2011, 22:3725-33.
75. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W: Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011, 286:7018-26.
76. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL: Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes & development 2011, 25:51-63.
77. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S: The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011, 147:759-72.
78. Kim NG, Koh E, Chen X, Gumbiner BM: E-cadherin mediates contact inhibition of proliferation through Hippo signalingpathway components. Proc Natl Acad Sci U SA 2011, 108:11930-35.
79. Sopko R, McNeill H: The skinny on Fat: an enormous cadherin that regulates cell adhesion, tissue growth, and planar cell polarity. Curr Opin Cell Biol 2009, 21:717-23.
80. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, Sapkota G, Pan D, Massague J: Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 2009, 139:757-69.
81. Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, Hida T, Tsujimura T, Osada H, Sekido Y: TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 2012, 209:479-94.
82. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, Guo K, Qi Z, Ponniah S, Hong W, Hunziker W: Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtrl. Proc Natl Acad Sci U S A 2007, 104:1631-6. (Pubitemid 46214642)
83. Makita R, Uchijima Y, Nishiyama K, Amano T, Chen Q, Takeuchi T, Mitani A, Nagase T, Yatomi Y, Aburatani H, Nakagawa O, Small EV, Cobo-Stark P, Igarashi P, Murakami M, Tominaga J, Sato T, Asano T, Kurihara Y, Kurihara H: Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol 2008, 294:F542-53. (Pubitemid 351442224)
84. Tian Y, Kolb R, Hong JH, Carroll J, Li D, You J, Bronson R, Yaffe MB, Zhou J, Benjamin T: TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol Cell Biol 2007, 27:6383-95. (Pubitemid 47435745)
85. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA, Sakuma R, Pawson T, Hunziker W, McNeill H, Wrana JL, Attisano L: The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 2010, 18:579-91.
86. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF: Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-61.
87. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, Avruch J: Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U SA 2011, 108:E1312-20.
88. Barry ER, Morikawa T, Butler BL, Shrestha K, De La Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD: Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013, 493:106-10.
89. Zecca M, Struhl G: A feed-forward circuit linking wingless, fatdachsous signaling, and the warts-hippo pathway to Drosophila wing growth. PLoS Biol 2010, 8:e1000386.
90. Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC: beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis. Cell 2012, 151:1457-73.
91. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999, 154:515-23. (Pubitemid 29094101)
92. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P: The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001, 15:968-80. (Pubitemid 32323547)
93. Konsavage WM, Jr., Kyler SL, Rennoll SA, Jin G, Yochum GS: Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 2012, 287:11730-9.
94. Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato S, Cordenonsi M, Piccolo S: Role of TAZ as Mediator of Wnt Signaling. Cell 2012, 151:1443-56.
95. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, Li T, Chan SW, Lim CJ, Hong W, Zhao S, Xiong Y, Lei QY, Guan KL: The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF(beta)-TrCP E3 ligase. J Biol Chem 2010, 285:37159-69.